Newsletter
Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

JAMA Editor’s Summary

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Editor's Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the issue.
January 25, 2022

Myocarditis After mRNA-Based COVID-19 Vaccination, Third Dose of BNT161b2 Vaccine and SARS-CoV-2 Infection Incidence, Penetrance of Deleterious Clinical Variants, and more

Editor’s Summary by Kristin Walter, MD, Associate Editor of JAMA, the Journal of the American Medical Association, for the January 25, 2022 issue.

You may also like

The Latest Health Podcasts. Delivered to Your Inbox.

Join Our Newsletter

Proudly supported by:

cover
Four Authors Untangle When Dad Has Dementia Virtual Q&A on the changes and challenges a dementia diagnosis.